Total Payments
$82,608
2024 Payments
$6,972
Companies
4
Transactions
25
Medicare Patients
2,864
Medicare Billing
$245,765
Payment Breakdown by Category
Consulting$80,915 (98.0%)
Travel$1,083 (1.3%)
Food & Beverage$609.89 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $80,915 | 17 | 98.0% |
| Travel and Lodging | $1,083 | 3 | 1.3% |
| Food and Beverage | $609.89 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agilent Technologies, Inc. | $63,815 | 8 | $0 (2023) |
| LEICA MICROSYSTEMS INC. | $11,700 | 7 | $0 (2020) |
| ABBVIE INC. | $6,972 | 9 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $121.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,972 | 9 | ABBVIE INC. ($6,972) |
| 2023 | $14,225 | 7 | Agilent Technologies, Inc. ($14,225) |
| 2021 | $49,590 | 1 | Agilent Technologies, Inc. ($49,590) |
| 2020 | $700.00 | 1 | LEICA MICROSYSTEMS INC. ($700.00) |
| 2019 | $8,000 | 5 | LEICA MICROSYSTEMS INC. ($8,000) |
| 2018 | $3,000 | 1 | LEICA MICROSYSTEMS INC. ($3,000) |
| 2017 | $121.35 | 1 | Alexion Pharmaceuticals, Inc. ($121.35) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | ELAHERE (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | ELAHERE (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $382.57 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $350.34 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $275.25 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $132.36 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $61.77 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $350.34 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $87.50 | General |
| 09/20/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,312.50 | General |
| 06/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 03/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $165.00 | General |
| 02/28/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,960.00 | General |
| 01/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $5,940.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 01/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $660.00 | General |
| 02/26/2021 | Agilent Technologies, Inc. | PD-L1 IHC 22C3 pharmDx (Device) | Consulting Fee | Cash or cash equivalent | $49,590.00 | General |
| Category: pharmDx | ||||||
| 09/28/2020 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 10/04/2019 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 07/30/2019 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 07/30/2019 | LEICA MICROSYSTEMS INC. | SCANSCOPE (510K) (Device) | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 05/20/2019 | LEICA MICROSYSTEMS INC. | SCANSCOPE (510K) (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 05/10/2019 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 06/19/2018 | LEICA MICROSYSTEMS INC. | DIGITAL MICROSCOPES (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 08/08/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 764 | 1,340 | $431,097 | $67,156 |
| 2022 | 13 | 668 | 1,282 | $325,018 | $56,870 |
| 2021 | 14 | 722 | 1,415 | $339,320 | $60,439 |
| 2020 | 14 | 710 | 1,251 | $319,370 | $61,300 |
Total Patients
2,864
Total Services
5,288
Medicare Billing
$245,765
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 142 | 142 | $129,826 | $21,531 | 16.6% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 83 | 126 | $50,400 | $8,859 | 17.6% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 45 | 287 | $40,180 | $6,964 | 17.3% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 17 | 36 | $62,779 | $5,948 | 9.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 128 | 188 | $33,864 | $5,942 | 17.5% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 31 | 34 | $23,800 | $4,206 | 17.7% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 40 | 41 | $15,170 | $2,657 | 17.5% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 11 | 39 | $13,377 | $2,075 | 15.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 55 | 57 | $10,887 | $1,685 | 15.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 64 | 165 | $10,725 | $1,664 | 15.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 20 | 59 | $9,440 | $1,426 | 15.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 21 | 43 | $12,211 | $1,401 | 11.5% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 45 | 46 | $8,740 | $1,395 | 16.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 12 | 23 | $6,230 | $1,054 | 16.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 24 | 25 | $2,250 | $241.75 | 10.7% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 26 | 29 | $1,218 | $108.79 | 8.9% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2022 | 121 | 123 | $102,336 | $18,594 | 18.2% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2022 | 50 | 356 | $49,840 | $8,949 | 18.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 59 | 89 | $35,600 | $6,373 | 17.9% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 19 | 96 | $32,928 | $5,185 | 15.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 114 | 161 | $27,370 | $5,163 | 18.9% |
| 88348 | Electron microscopy for diagnosis | Facility | 2022 | 47 | 50 | $18,500 | $3,358 | 18.2% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 23 | 24 | $16,800 | $2,779 | 16.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 76 | 199 | $12,935 | $2,077 | 16.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 54 | 57 | $10,887 | $1,708 | 15.7% |
About Dr. Anthony Sisk, DO
Dr. Anthony Sisk, DO is a Anatomic Pathology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1619294923.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Sisk, DO has received a total of $82,608 in payments from pharmaceutical and medical device companies, with $6,972 received in 2024. These payments were reported across 25 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($80,915).
As a Medicare-enrolled provider, Sisk has provided services to 2,864 Medicare beneficiaries, totaling 5,288 services with total Medicare billing of $245,765. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Location Los Angeles, CA
- Active Since 04/26/2010
- Last Updated 08/19/2015
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619294923
Products in Payments
- PD-L1 IHC 22C3 pharmDx (Device) $49,590
- DIGITAL MICROSCOPES (Device) $8,575
- PD-L1 IHC 28-8 PHARMDX (Device) $8,040
- ELAHERE (Drug) $6,972
- SCANSCOPE (510K) (Device) $3,125
- SOLIRIS (Drug) $121.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Los Angeles
Peter Tontonoz, Md, MD
Anatomic Pathology — Payments: $13.6M
Anatomic Pathology $13.6M
Sheeja Pullarkat, Md, MD
Anatomic Pathology — Payments: $213,828
Anatomic Pathology $213,828
Michael Press, Md, MD
Anatomic Pathology — Payments: $98,333
Anatomic Pathology $98,333
Scott Nelson, Md, MD
Anatomic Pathology — Payments: $80,500
Anatomic Pathology $80,500
Dinesh Rao, Md, MD
Anatomic Pathology — Payments: $51,417
Anatomic Pathology $51,417
Hanlin Wang, Md, MD
Anatomic Pathology — Payments: $20,198
Anatomic Pathology $20,198